| |
| |
|
| Insider
Information: |
Lawrence David |
| Relationship: |
Chief, Bus. Ops & PAO |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,811 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,811 |
|
|
| Total
Value |
$6,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief, Bus. Ops & PAO |
2020-12-01 |
13,811 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-03-10 |
4 |
AS |
$17.22 |
$31,180 |
D/D |
(1,800) |
14,616 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2020-11-09 |
4 |
D |
$0.86 |
$881 |
D/D |
(1,024) |
14,952 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-12-16 |
4 |
OE |
$8.14 |
$40,700 |
D/D |
5,000 |
15,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-01-22 |
4 |
OE |
$8.14 |
$40,700 |
D/D |
5,000 |
15,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-02-02 |
4 |
OE |
$8.14 |
$40,700 |
D/D |
5,000 |
15,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,015 |
15,976 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2011-12-01 |
4 |
AS |
$22.92 |
$226,816 |
D/D |
(9,896) |
16,249 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-10-07 |
4 |
AS |
$29.82 |
$7,455 |
D/D |
(250) |
16,369 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
16,416 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,573 |
16,619 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-05-23 |
4 |
AS |
$24.11 |
$21,347 |
D/D |
(883) |
17,424 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-22 |
4/A |
S |
$19.55 |
$116,622 |
D/D |
(5,941) |
17,825 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-12-03 |
4 |
AS |
$24.21 |
$225,438 |
D/D |
(9,313) |
17,936 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-12-07 |
4 |
OE |
$5.85 |
$6 |
D/D |
1 |
17,937 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
18,266 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-04-23 |
4 |
AS |
$23.65 |
$21,197 |
D/D |
(883) |
18,307 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-22 |
4 |
AS |
$19.55 |
$116,622 |
D/D |
(5,941) |
19,190 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-12 |
4 |
OE |
$5.85 |
$40,950 |
D/D |
7,000 |
19,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-10-07 |
4 |
AS |
$33.60 |
$8,400 |
D/D |
(250) |
19,944 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
20,194 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-03-10 |
4 |
OE |
$8.14 |
$97,680 |
D/D |
12,000 |
22,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-09 |
4 |
AS |
$19.51 |
$26,895 |
D/D |
(1,365) |
23,766 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,093 |
24,030 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-04 |
4 |
S |
$29.39 |
$623,425 |
D/D |
(21,106) |
24,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
24,550 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
